Who owns TELIX PHARMACEUTICAL LTD SPONSORED?
- Ticker: TLX
- CUSIP Number: 87961m105
Tip: Access positions for across all investors
Analyze quarterly positions in Telix Pharmaceutical Ltd Sponsored with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Telix Pharmaceutical Ltd Sponsored stock
Who bought or sold TELIX PHARMACEUTICAL LTD SPONSORED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Portolan Capital Management | 541k | $5.2M | 100% | Mar 2026 |
|
| Lazard Asset Management | 290k | $2.8M | 16% | Mar 2026 |
|
| Portland Investment Counsel | 266k | $2.1M | 108% | Dec 2025 |
|
| Private Advisor | 174k | $1.7M | 276% | Mar 2026 |
|
| Integrated Wealth Concepts | 164k | $1.6M | 100% | Mar 2026 |
|
| Raiffeisen Bank International | 130k | $1.2M | 100% | Mar 2026 |
|
| FMR | 124k | $926k | 4% | Dec 2025 |
|
| Morgan Stanley | 116k | $1.1M | 560% | Mar 2026 |
|
| Marshall Wace | 47k | $350k | -4% | Dec 2025 |
|
| Mariner Wealth Advisors | 43k | $415k | 19% | Mar 2026 |
|
| Quadrature Capital | 37k | $276k | 100% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 35k | $334k | 100% | Mar 2026 |
|
| JustInvest | 33k | $318k | 83% | Mar 2026 |
|
| UBS Group | 32k | $309k | 1545% | Mar 2026 |
|
| Vident Advisory | 27k | $204k | 100% | Dec 2025 |
|
| IHT Wealth Management | 25k | $189k | -4% | Dec 2025 |
|
| Old Mission Capital | 15k | $111k | 100% | Dec 2025 |
|
| XY Capital | 13k | $120k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 12k | $115k | 700% | Mar 2026 |
|
| XTX Topco | 12k | $89k | 100% | Dec 2025 |
|
| Bank of America Corporation | 10k | $96k | 100% | Mar 2026 |
|
| Rhumbline Advisers | 9.8k | $94k | -9% | Mar 2026 |
|
| Goss Wealth Management | 1.9k | $18k | 0% | Mar 2026 |
|
| EverSource Wealth Advisors | 1.8k | $18k | 104% | Mar 2026 |
|
| Ronald Blue Trust | 742.00 | $7.1k | -76% | Mar 2026 |
|
| Aspect Partners | 380.00 | $3.6k | 8% | Mar 2026 |
|
| BlackRock | 352.00 | $3.4k | 300% | Mar 2026 |
|
| Advisor Group Holdings | 314.00 | $2.4k | -7% | Dec 2025 |
|
| Assetmark | 153.00 | $1.5k | 240% | Mar 2026 |
|
| CVA Family Office | 127.00 | $1.2k | 100% | Mar 2026 |
|
| SRS Capital Advisors | 125.00 | $9.9k | -88% | Mar 2026 |
|
| Bell Investment Advisors | 70.00 | $669.998000 | 100% | Mar 2026 |
|
| NISA Investment Advisors | 65.00 | $621.998000 | 100% | Mar 2026 |
|
| MV Capital Management | 61.00 | $584.001800 | 455% | Mar 2026 |
|
| Smartleaf Asset Management | 37.00 | $332.001000 | -49% | Mar 2026 |
|
| Transamerica Financial Advisors | 28.00 | $266.999600 | 12% | Mar 2026 |
|
| Farther Finance Advisors | 9.00 | $82.999800 | 0% | Mar 2026 |
|
| SageView Advisory Group | 2.00 | $15.000000 | 100% | Dec 2025 |
|
| Parallel Advisors | 1.00 | $13.000000 | -92% | Mar 2026 |
|
Who sold out of Telix Pharmaceutical Ltd Sponsored?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Dec 2025 | 40k | $300k |
| Jpmorgan Chase & Co | Sep 2025 | 25k | $243k |
| Citadel Advisors | Dec 2025 | 23k | $172k |
| Millennium Management | Dec 2025 | 20k | $148k |
| Point72 Asset Management | Dec 2025 | 18k | $138k |
| Independence Bank of Kentucky | Dec 2025 | 66.00 | $493.996800 |
| Larson Financial Group | Sep 2025 | 53.00 | $506.998000 |
| True Wealth Design | Dec 2025 | 3.00 | $23.000100 |